Feeney Patent Law Group

Feeney Patent Law Group

Life Science IP for Southern New England

 

Feeney Law Group provides legal expertise for new business start-ups in biological, chemical, design, and mechanical arts. Our legal and industry experts specialize in identifying and protecting intellectual property assets in the biotech, life sciences, engineering, and healthcare sectors. We assist small business startups with the detailed planning and compliance that is required when starting a new business.

Feeney Law advises clients in patent strategy, portfolio management, patent prosecution, trademark protection, copyright filings, and trade secret matters. Additionally, our founding partner, Mr. Alan Feeney, Esq., regularly advises Wall Street investors for Fortune 500 companies. He has over 20 years of legal experience specializing in intellectual property law and holds an advanced Legal Letter Master (LL.M.) law degree in Intellectual Property. This distinction is a post-graduate, advanced law degree that focuses solely on critical nature and detailed nuances of one of the most dynamic fields of legal practice today: intellectual property.

Working as the U.S. Patent Counsel for IPSEN located in Paris, France, Mr. Feeney developed intellectual property strategies to protect the company’s peptide and protein products and drug development candidates. He successfully drafted and defended over 100 patents. While at IPSEN, Mr. Feeney also served as patent counsel for many international joint ventures and partnerships. Mr. Feeney was the architect of the argument leading to European decision T 0578/06 which provided for the submission of post-published evidence to support inventive step.

Alan F. Feeney has over 25 years of legal experience and over 20 years specializing in intellectual property law. Working as the U.S. Patent Counsel for IPSEN located in Paris, France, Alan developed intellectual property strategies to protect the company’s peptide and protein products and drug development candidates. He successfully drafted and defended over 100 patents. While at IPSEN, Alan also served as patent counsel for many international joint ventures and partnerships.

Alan graduated in 1997 from the University of New Hampshire with a Master of Laws in Intellectual Property degree (LL.M.). He earned his Juris Doctor degree from the University of Miami School of Law in 1990. He holds a Bachelor of Science degree in Chemistry from Boston College.

MEMBERSHIPS
The Bar for the State of Rhode Island (2014)
Federal Bars for the Northern and Western Districts of New York (1999)
Federal Bar for the District of Massachusetts (1998)
Registration United States Patent and Trademark Office (1997)
The Bar for the Commonwealth of Massachusetts (1996)
Federal Bar for the Southern District of Florida (1994)
The Bar for the State of Florida (1990)

 

Research Activities

  • ip intellectual property patents trademarks contracts licensing
  • patent portfolio management
  • patent strategy
  • patent review
  • oncology
  • endocrinology
  • diabetes
  • metabolism
  • protein
  • peptide
  • orphan drugs
  • small molecule
  • large molecule

 

Products or Services

  • intellectual property
  • patent
  • patents
  • ip intellectual property patents trademarks contracts licensing
  • patent review
  • patent strategy
  • patent portfolio management
  • trademark
  • trade secrets
  • copyright
  • copyrights
  • trademarks
  • biotechnology

 

Markets Served

  • biotechnology
  • life sciences

 

Patents

Drafter of Abaloparatide, Relamorelin, RM-493 and Taspoglutide as potential therapeutic agents for treating osteoporosis, GI functional disorders, obesity and type II diabetes, respectively

Architect of the argument leading to European decision T 0578/06 which provided for the submission of post-published evidence to support inventive step

Drafted over 100 US and international patent applications

Senior Patent Counsel responsible for the management of patent portfolios for U.S., Ireland and Spain

Founding member of ERINE collaborative with Erasmus University (Rotterdam, NL) - R& D for therapeutics in endocrinology, diabetes and metabolism

Instrumental in securing one of the first grants ($1 million) awarded by the Massachusetts Life Sciences Center to one of IPSEN Pharmaceutical’s collaborators